AVRO - AVROバイオ （AVROBIO Inc.）AVROのニュース
AVROBIO GAAP EPS of -$0.57 misses by $0.12 2023/03/23 11:56:54 Seeking Alpha
AVROBIO press release (AVRO): Q4 GAAP EPS of -$0.57 misses by $0.12.As of Dec
AVROBIO Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update 2023/03/23 11:00:00 Business Wire
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company working to free people from a lifetime of genetic disease, today reported
AVROBIO (AVRO) Investor Presentation - Slideshow 2023/03/10 13:42:50 Seeking Alpha
The following slide deck was published by AVROBIO, Inc.
AVROBIO to Participate in Cowen’s 43rd Annual Health Care Conference 2023/03/03 12:00:00 Wallstreet:Online
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company working to free people from a lifetime of genetic disease, today announced that members of its senior management team are scheduled to participate in a panel titled “Orphan Neuro Corporate Panel” at Cowen’s 43rd Annual Health Care Conference on Tuesday, March 7, 2023 at 10:30 AM ET at the Boston Marriott Copley Place
What Can AVROBIO Inc. (NASDAQ: AVRO) Expect In 2023? 2023/02/24 13:00:00 Stocks Register
AVROBIO Inc. (NASDAQ:AVRO) price on Thursday, February 23, fall -18.63% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.31. A look at the stock’s price movement, the close in the last trading session was $1.61, moving within a range at $1.29 and $1.60. The beta value (5-Year … What Can AVROBIO Inc. (NASDAQ: AVRO) Expect In 2023? Read More »
AVROBIO GAAP EPS of -$0.57 misses by $0.12 2023/03/23 11:56:54 Seeking Alpha
AVROBIO press release (AVRO): Q4 GAAP EPS of -$0.57 misses by $0.12.As of Dec
AVROBIO Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update 2023/03/23 11:00:00 Business Wire
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company working to free people from a lifetime of genetic disease, today reported
AVROBIO (AVRO) Investor Presentation - Slideshow 2023/03/10 13:42:50 Seeking Alpha
The following slide deck was published by AVROBIO, Inc.
AVROBIO to Participate in Cowen’s 43rd Annual Health Care Conference 2023/03/03 12:00:00 Wallstreet:Online
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company working to free people from a lifetime of genetic disease, today announced that members of its senior management team are scheduled to participate in a panel titled “Orphan Neuro Corporate Panel” at Cowen’s 43rd Annual Health Care Conference on Tuesday, March 7, 2023 at 10:30 AM ET at the Boston Marriott Copley Place
What Can AVROBIO Inc. (NASDAQ: AVRO) Expect In 2023? 2023/02/24 13:00:00 Stocks Register
AVROBIO Inc. (NASDAQ:AVRO) price on Thursday, February 23, fall -18.63% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.31. A look at the stock’s price movement, the close in the last trading session was $1.61, moving within a range at $1.29 and $1.60. The beta value (5-Year … What Can AVROBIO Inc. (NASDAQ: AVRO) Expect In 2023? Read More »
AVROBIO Inc. (AVRO) did well last session? 2022/09/28 12:32:00 US Post News
A share of AVROBIO Inc. (NASDAQ:AVRO) closed at $0.65 per share on Tuesday, down from $0.73 day before. While AVROBIO Inc. has underperformed by -10.23%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AVRO fell by -89.04%, with highs and lows ranging from $6.62 to $0.66, […]
AVROBIO, Inc.: AVROBIO to Present New Preclinical Data on Vector Safety at ESGCT Annual Congress 2022/09/27 11:03:00 Finanz Nachrichten
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company working to free people from a lifetime of genetic disease, today announced that it will present new preclinical data on …
AVROBIO Inc. (AVRO) can excel with these strategies 2022/09/21 15:32:00 US Post News
A share of AVROBIO Inc. (NASDAQ:AVRO) closed at $0.77 per share on Tuesday, down from $0.80 day before. While AVROBIO Inc. has underperformed by -3.36%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AVRO fell by -87.57%, with highs and lows ranging from $6.62 to $0.74, […]